NCT05462925

Brief Summary

Reduced arm and hand function has a significant impact on independence and quality of life after spinal cord injury. Functional electrical stimulation therapy (FES-T) is a treatment that can produce improvements in reaching and grasping function after neurological injuries. However, not all paralyzed muscles respond equally well to the therapy. Currently, therapists cannot predict which muscles will respond, limiting their ability to create a personalized therapy plan that can maximize outcomes while making the best use of the limited treatment time available. The objective of this study is to develop a diagnostic method that will allow therapists to quickly and easily screen muscles in the clinic, in order to predict how they will respond to FES-T. Participants with cervical spinal cord injury will receive FES-T through the Rocket Family Upper Extremity Clinic at the Toronto Rehabilitation Institute - University Health Network. Muscles receiving training will undergo a electrophysiological examination before the start of therapy, and will then be tracked for strength recovery over the course of 30 sessions. Lastly, signal processing and machine learning techniques will be applied to the electrophysiological data to predict the recovery profile of each muscle. The significance of this work will be to provide personalized therapy planning in FES-T, leading to more effective use of healthcare resource as well as improved outcomes.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jul 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 4, 2022

Completed
14 days until next milestone

First Posted

Study publicly available on registry

July 18, 2022

Completed
2 days until next milestone

Study Start

First participant enrolled

July 20, 2022

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
Last Updated

January 15, 2025

Status Verified

January 1, 2025

Enrollment Period

2.5 years

First QC Date

July 4, 2022

Last Update Submit

January 13, 2025

Conditions

Keywords

Spinal cord injuryFunctional electrical stimulationUpper limbElectromyographyPrediction.

Outcome Measures

Primary Outcomes (1)

  • Muscle strength recovery profile

    Change over time in manual muscle testing conducted on each treated muscle.

    Muscle strength assessed at each of 30 therapy sessions (3-5 sessions per week).

Secondary Outcomes (1)

  • Surface electromyography signal features

    Baseline (required). End of therapy (6-10 weeks; optional).

Study Arms (1)

Functional electrical stimulation therapy

EXPERIMENTAL

Participants will receive 30 sessions of upper limb functional electrical stimulation therapy. Sessions will be 1 hour in length and take place 3-5 times per week.

Device: Functional electrical stimulation therapy.

Interventions

Functional electrical stimulation therapy will be delivered using the MyndMove system (MyndTec, Inc., Mississauga, Canada).

Functional electrical stimulation therapy

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Cervical spinal cord injury
  • Paralysis or paresis in at least one upper extremity
  • At least 6 months post SCI
  • Able to understand and follow instructions
  • Able to tolerate being in a seated position for a least one hour required to deliver upper limb therapy
  • Willing to attend treatment sessions and all assessment sessions
  • Able to understand and provide informed consent
  • Male and female participants ≥ 18 years of age at the time of enrollment

You may not qualify if:

  • Previous history of any other neuromuscular disorder or conditions that may affect motor response
  • Upper extremity injury or condition prior to SCI that limits the function of the hand or arm
  • In the judgment of the medical provider, the participant has medical complications that may interfere with the execution of the study
  • Currently enrolled in another upper limb study and/ or has received MyndMove Therapy within the past 3 months
  • Botulinum toxin injection into affected upper extremity and the muscle targeted by MyndMove® therapy within 3 months prior to the study start. No botulinum toxin injections in the upper extremity during the study treatment.
  • Females who are pregnant or planning to become pregnant in the duration of the trial
  • Regional disorder of the upper extremities such as fracture, dislocation, or joint contractures to less than 50% of the expected range of motion

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Toronto Rehabilitation Institute - University Health Network

Toronto, Ontario, M4G 3V9, Canada

Location

Related Publications (1)

  • Balbinot G, Li G, Chen A, Eftekhar P, Ma W, Kalsi-Ryan S, Zariffa J. Upper Extremity Muscle Recovery Profiles With Functional Electrical Stimulation Therapy in Chronic Spinal Cord Injury. Neuromodulation. 2025 Oct 16:S1094-7159(25)01026-8. doi: 10.1016/j.neurom.2025.08.416. Online ahead of print.

MeSH Terms

Conditions

Spinal Cord Injuries

Condition Hierarchy (Ancestors)

Spinal Cord DiseasesCentral Nervous System DiseasesNervous System DiseasesTrauma, Nervous SystemWounds and Injuries

Study Officials

  • José Zariffa, PhD

    University Health Network, Toronto

    PRINCIPAL INVESTIGATOR
  • Sukhvinder Kalsi-Ryan, PhD

    University Health Network, Toronto

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Model Details: This prognostic study examines how baseline measurements predict therapy response in a single group of participants.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 4, 2022

First Posted

July 18, 2022

Study Start

July 20, 2022

Primary Completion

December 31, 2024

Study Completion

December 31, 2024

Last Updated

January 15, 2025

Record last verified: 2025-01

Data Sharing

IPD Sharing
Will share

De-identified data may be shared following study completion upon reasonable request to the investigators and completion of a data sharing agreement.

Time Frame
Once study has been published, the datasets corresponding to the analyses described will be shared upon request.
Access Criteria
Data sharing will require completion of a data sharing agreement. Interested parties should contact the principal investigator.

Locations